ADNEX model: Stage I
The ADNEX model is a risk prediction model that can reliably distinguish between benign, borderline,stage I invasive, stage II-IV invasive, and secondary metastatic adnexal ovarian tumours. 

This model calculates the probability that a tumour is stage I. 

It is adviced to use the composite model since it provides more extensive prediction of the tumour stage. The composite can be found here: http://www.evidencio.com/public/show/946
Research authors: Ben van Calster, Kirsten van Hoorde, Lil Valentin, Antonia C. Testa, Daniela Fischerova, Caroline van Holsbeke, Luca Savelli, Dorella Franchi, Elisabeth Epstein, Jeroen Kaijser, Vanya van Belle, Artur Czekierdowski, Stefano Guerriero, Robert Fruscio, Chiara Lanzani, Felice Scala, Tom Bourne, Dirk Timmerman
Details Custom formula Study characteristics Files & References
★★★
Model author
Model ID
925
Version
1.9
Revision date
2018-06-11
Specialty
MeSH terms
  • Gynecology
  • Surgical Oncology
  • Ovarian Cancer
  • Model type
    Custom model (Conditional)
    Status
    public
    Rating
    Share
    Condition Formula

    Additional information

    Data on 5909 women were used.. The observed rate of malignancy varied between 22% and 66% in oncology centres and between 0% and 30% in other hospitals.

    Descriptive statistics shown are characteristics of the patients in the Benign group. Follow the linked reference to see all the patient characteristics of all the patients. 

    Study Population

    Total population size: 5909
    Males: {{ model.numberOfMales }}
    Females: {{ model.numberOfFemales }}

    Continuous characteristics

    Name LL Q1 Median Q3 UL Unit
    Age 32 42 54 years
    serum CA-125 11 18 39 U/mL
    Maximum diameter of lesion 45 63 87 mm
    Proportion solid tissue if present 20 42 100 mm

    Categorical characteristics

    Name Subset / Group Nr. of patients
    No of papillary projections: 0 3424
    1 333
    2 80
    3 66
    >3 77
    Acoustic shadows No 3304
    Yes 676
    Ascites No 3916
    Yes 64
    Family history of ovarian cancer No 3901
    Yes 79
    Solid tissue Absent 2658
    Present 1322
    Cyst locules ≤10 3781
    >10 199

    Risk of stage I ovarian tumour:
    ...
    %

    {{ resultSubheader }}

    {{ variable.title }}

    {{ model.survival.PITTitle }}

    {{ model.survival.YNETitle }}

    Result
    Note
    Notes are only visible in the result download and will not be saved by Evidencio

    Risk of stage I ovarian tumour: %

    {{ resultSubheader }}

    Outcome stratification

    Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

    Conditional information

    Result interpretation

    The model uses three clinical predictors (age, serum CA-125 level, type of centre) and six ultrasound predictors (maximal diameter of lesion, proportion of solid tissue, more than 10 cyst locules, number of papillary projections, acoustic shadows, and ascites).

    Serum CA-125 level and proportion of solid tissue were the strongest predictors.

    The ADNEX model has the potential to change management decisionsfor women with an adnexal tumour. This could impact considerably on the morbidity and mortality associated with adnexal pathology.

    {{ file.classification }}

    Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

    Comments
    Rating
    Comment
    Please enter a comment of rating
    Comments are visible to anyone

    Model feedback

    No feedback yet 1 Comment {{ model.comments.length }} Comments
    Not rated | On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
    {{ comment.content }}
    logo

    Please sign in to enable Evidencio print features

    In order to use the Evidencio print features, you need to be logged in.
    If you don't have an Evidencio Community Account you can create your free personal account at:

    https://www.evidencio.com/registration

    Printed results - Examples {{ new Date().toLocaleString() }}


    Evidencio Community Account Benefits


    With an Evidencio Community account you can:

    • Create and publish your own prediction models.
    • Share your prediction models with your colleagues, research group, organization or the world.
    • Review and provide feedback on models that have been shared with you.
    • Validate your models and validate models from other users.
    • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
    • Use and save prediction models and their data.
    • Use patient specific protocols and guidelines based on sequential models and decision trees.
    • Stay up-to-date with new models in your field as they are published.
    • Create your own lists of favorite models and topics.
    A personal Evidencio account is free, with no strings attached! Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.

    Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.